ALK and non-small cell lung carcinoma: At a first glance, this is consistent with the fact that EGFR-mutations and ALK-fusions have been largely described as mutually exclusive in untreated NSCLC and as mutual causes of acquired resistance to ALK-TKIs and EGFR-TKIs, respectively [17,18,43].